SG10201500719VA - Transformation plasmid - Google Patents
Transformation plasmidInfo
- Publication number
- SG10201500719VA SG10201500719VA SG10201500719VA SG10201500719VA SG10201500719VA SG 10201500719V A SG10201500719V A SG 10201500719VA SG 10201500719V A SG10201500719V A SG 10201500719VA SG 10201500719V A SG10201500719V A SG 10201500719VA SG 10201500719V A SG10201500719V A SG 10201500719VA
- Authority
- SG
- Singapore
- Prior art keywords
- transformation plasmid
- plasmid
- transformation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29992210P | 2010-01-29 | 2010-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201500719VA true SG10201500719VA (en) | 2015-03-30 |
Family
ID=44319445
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012050795A SG182445A1 (en) | 2010-01-29 | 2011-01-28 | Transformation plasmid |
| SG2012050803A SG182446A1 (en) | 2010-01-29 | 2011-01-28 | Transformation plasmid |
| SG10201500719VA SG10201500719VA (en) | 2010-01-29 | 2011-01-28 | Transformation plasmid |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012050795A SG182445A1 (en) | 2010-01-29 | 2011-01-28 | Transformation plasmid |
| SG2012050803A SG182446A1 (en) | 2010-01-29 | 2011-01-28 | Transformation plasmid |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20110189758A1 (en) |
| EP (4) | EP2530150A4 (en) |
| JP (2) | JP5841432B2 (en) |
| KR (2) | KR101850162B1 (en) |
| CN (2) | CN102741407B (en) |
| CA (2) | CA2787590C (en) |
| SG (3) | SG182445A1 (en) |
| WO (3) | WO2011093465A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9730968B2 (en) | 2008-04-17 | 2017-08-15 | Anaeropharma Science, Inc. | Therapeutic agent for ischemic diseases |
| CN102741407B (en) | 2010-01-29 | 2014-12-10 | 阿内罗药物科学株式会社 | Transformation plasmid |
| JPWO2013008881A1 (en) | 2011-07-13 | 2015-02-23 | 株式会社アネロファーマ・サイエンス | Drug for ischemic disease |
| US9252578B2 (en) | 2013-03-15 | 2016-02-02 | Hubbell Incorporated | Cable connector and electrical box assembly |
| EP3842050B1 (en) * | 2014-01-10 | 2024-06-12 | Teikyo Heisei University | Recombinant obligate anaerobic gram-positive bacteria |
| US20150232578A1 (en) | 2014-02-14 | 2015-08-20 | Symvivo Corporation | Hybrid proteins and uses thereof |
| CA2947525C (en) * | 2014-05-01 | 2023-09-05 | Anaeropharma Science, Inc. | Heterologous polypeptide expression cassette |
| SG11201609108TA (en) | 2014-05-02 | 2016-12-29 | Univ Shinshu | Antibody gene expression-secretion system |
| ES2884948T3 (en) * | 2014-12-03 | 2021-12-13 | Azusapharma Sciences Inc | Co-expression plasmid |
| CN107208108B (en) * | 2015-01-19 | 2019-05-17 | 国立大学法人信州大学 | Therapeutic agent for ischemic diseases |
| CN110448681B (en) * | 2019-08-26 | 2020-12-15 | 君维安(武汉)生命科技有限公司 | Combined medicine for malignant tumor immunotherapy |
| JPWO2021038975A1 (en) | 2019-08-28 | 2021-03-04 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984513B2 (en) | 1994-03-03 | 2006-01-10 | The Board Of Trustees Of The Leland Stanford Junior University | Anaerobe targeted enzyme-mediated prodrug therapy |
| US6416754B1 (en) | 1994-03-03 | 2002-07-09 | The Board Of Trustees Of The Leland Stanford Junior University | Anaerobe targeted enzyme-mediated prodrug therapy |
| JP3642755B2 (en) | 2000-09-21 | 2005-04-27 | 純 天野 | Drugs for gene therapy using anaerobic bacteria |
| CA2342040C (en) | 2000-09-21 | 2012-07-10 | Kyowa Hakko Kogyo Co., Ltd. | Anaerobic bacterium as a drug for cancer gene therapy |
| JP2004528278A (en) | 2000-12-18 | 2004-09-16 | ボード オブ レジェンツ，ザ ユニバーシティー オブ テキサス システム | Localized area chemotherapy and radiation treatment using in situ hydrogel |
| EP1227152A1 (en) | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Bacterial strain and genome of bifidobacterium |
| KR100457879B1 (en) | 2001-02-24 | 2004-11-18 | 주식회사 비피도 | Plasmid originated from Bifidobacterium, recombinant expression vector using the plasmid and transformation method |
| CN101869716B (en) | 2001-12-31 | 2013-12-11 | 抗癌公司 | System for monitoring bacterial tumor treatment |
| CA2542922A1 (en) * | 2003-10-24 | 2005-05-06 | Queensland University Of Technology | Protein expression |
| EP1655370A1 (en) | 2004-11-05 | 2006-05-10 | Gesellschaft für Biotechnologische Forschung | Bacterial vector |
| SG158077A1 (en) | 2004-11-24 | 2010-01-29 | Anaeropharma Science Inc | Novel shuttle vector |
| KR100967868B1 (en) | 2004-12-17 | 2010-07-05 | 베쓰 이스라엘 디코니스 메디칼 센터 | Compositions for bacterial mediated gene silencing and methods of using same |
| CA2646244A1 (en) | 2006-03-27 | 2007-10-04 | Government Of The United States Of Americas, As Represented By The Secre | Tetracycline compounds and methods of treatment |
| US20090291469A1 (en) | 2006-04-13 | 2009-11-26 | David Peter R | Compositions and Methods for Producing Fermentation Products and Residuals |
| JP5048661B2 (en) * | 2006-05-24 | 2012-10-17 | 株式会社アネロファーマ・サイエンス | Gene transport carrier production method |
| CN1974759B (en) | 2006-07-26 | 2010-06-09 | 吉林大学 | Attenuated salmonella transporting recombinant plasmid and its application in treating tumor |
| US20130095072A1 (en) | 2010-01-29 | 2013-04-18 | Anaeropharma Science, Inc. | Therapeutic agent for ischemic diseases |
| PT2274422T (en) | 2008-04-17 | 2017-06-28 | Anaeropharma Science Inc | Expression vector |
| WO2010126073A1 (en) | 2009-04-28 | 2010-11-04 | 協和発酵キリン株式会社 | Expression cassette for secretion/expression of polypeptide, and use thereof |
| CN102741407B (en) | 2010-01-29 | 2014-12-10 | 阿内罗药物科学株式会社 | Transformation plasmid |
-
2011
- 2011-01-28 CN CN201180007461.6A patent/CN102741407B/en active Active
- 2011-01-28 CN CN201180007535.6A patent/CN102834514B/en active Active
- 2011-01-28 US US13/016,134 patent/US20110189758A1/en not_active Abandoned
- 2011-01-28 JP JP2011551941A patent/JP5841432B2/en active Active
- 2011-01-28 CA CA2787590A patent/CA2787590C/en active Active
- 2011-01-28 WO PCT/JP2011/051802 patent/WO2011093465A1/en active Application Filing
- 2011-01-28 SG SG2012050795A patent/SG182445A1/en unknown
- 2011-01-28 JP JP2011551940A patent/JP5836129B2/en active Active
- 2011-01-28 EP EP11737175.7A patent/EP2530150A4/en not_active Withdrawn
- 2011-01-28 EP EP15154670.2A patent/EP2910636B1/en active Active
- 2011-01-28 CA CA2787787A patent/CA2787787A1/en not_active Abandoned
- 2011-01-28 SG SG2012050803A patent/SG182446A1/en unknown
- 2011-01-28 EP EP15151013.8A patent/EP2896695A3/en not_active Withdrawn
- 2011-01-28 WO PCT/JP2011/051804 patent/WO2011093467A1/en active Application Filing
- 2011-01-28 KR KR1020127022063A patent/KR101850162B1/en active IP Right Grant
- 2011-01-28 KR KR1020127022066A patent/KR20120112824A/en not_active Application Discontinuation
- 2011-01-28 EP EP11737177.3A patent/EP2530151A4/en not_active Withdrawn
- 2011-01-28 US US13/015,806 patent/US8535939B2/en active Active
- 2011-01-28 WO PCT/JP2011/051808 patent/WO2011093468A1/en active Application Filing
- 2011-01-28 US US13/015,918 patent/US9228191B2/en active Active
- 2011-01-28 SG SG10201500719VA patent/SG10201500719VA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101850162B1 (en) | 2018-04-18 |
| EP2530150A4 (en) | 2013-10-23 |
| CN102834514B (en) | 2015-08-19 |
| EP2530151A1 (en) | 2012-12-05 |
| EP2530151A4 (en) | 2013-10-23 |
| JPWO2011093465A1 (en) | 2013-06-06 |
| KR20120128638A (en) | 2012-11-27 |
| US20110189757A1 (en) | 2011-08-04 |
| SG182445A1 (en) | 2012-08-30 |
| US20110190472A1 (en) | 2011-08-04 |
| CN102741407A (en) | 2012-10-17 |
| EP2910636B1 (en) | 2018-01-17 |
| CN102834514A (en) | 2012-12-19 |
| CA2787787A1 (en) | 2011-08-04 |
| US8535939B2 (en) | 2013-09-17 |
| EP2910636A2 (en) | 2015-08-26 |
| JP5841432B2 (en) | 2016-01-13 |
| CN102741407B (en) | 2014-12-10 |
| WO2011093467A1 (en) | 2011-08-04 |
| JP5836129B2 (en) | 2015-12-24 |
| SG182446A1 (en) | 2012-08-30 |
| WO2011093468A1 (en) | 2011-08-04 |
| WO2011093465A1 (en) | 2011-08-04 |
| EP2910636A3 (en) | 2015-12-02 |
| KR20120112824A (en) | 2012-10-11 |
| US20110189758A1 (en) | 2011-08-04 |
| EP2530150A1 (en) | 2012-12-05 |
| US9228191B2 (en) | 2016-01-05 |
| CA2787590A1 (en) | 2011-08-04 |
| EP2896695A3 (en) | 2015-09-23 |
| CA2787590C (en) | 2019-01-15 |
| JPWO2011093467A1 (en) | 2013-06-06 |
| EP2896695A2 (en) | 2015-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3342786T3 (en) | Anti-dll3-antistof | |
| AP3107A (en) | 5-Alkynyl-pyrimidines | |
| EP2566479A4 (en) | Azaindazoles | |
| EP2640189A4 (en) | 3-deutero-pomalidomide | |
| SG10201500719VA (en) | Transformation plasmid | |
| EP2651505A4 (en) | Electroporation-induced electrosensitization | |
| DK3466977T3 (en) | Anti-vla-4-antistoffer | |
| EP2641891A4 (en) | Pkc- activator | |
| HK1183325A1 (en) | Self-deleting plasmid | |
| IL224507A (en) | Next-instruction-type field | |
| GB201001385D0 (en) | Cable-tidies | |
| GB2481646B (en) | Agrictultural implement | |
| GB201007450D0 (en) | Transformation | |
| TWI366500B (en) | Tongs | |
| AU4536P (en) | TB01 Tibouchina urvilleana | |
| AU4937P (en) | FlatinsulGL Myoporum insulare | |
| AU4931P (en) | FlatwaxDarkGL Chamelaucium uncinatum | |
| AU4822P (en) | FlatwaxwhiteGL Chamelaucium uncinatum | |
| AU4932P (en) | FlatwaxpinkGL Chamelaucium uncinatum | |
| GB201010836D0 (en) | Easy squeezy | |
| GB201118780D0 (en) | Energy-liberating transformation | |
| GB201006710D0 (en) | Cart | |
| GB201015314D0 (en) | Improved fly-hook | |
| AU2010278V (en) | Little Tuffy Lomandra confertifolia | |
| AU2010194V (en) | CalpenGL Calothamnus quadrifidus |